HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana Maria Oliveira Battastini Selected Research

brilliant blue (brilliant blue FCF)

3/2020P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study.
1/2016Role of P2X7 Receptor in an Animal Model of Mania Induced by D-Amphetamine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana Maria Oliveira Battastini Research Topics

Disease

24Glioma (Gliomas)
01/2021 - 10/2004
20Neoplasms (Cancer)
08/2022 - 06/2009
8Glioblastoma (Glioblastoma Multiforme)
07/2021 - 06/2009
6Inflammation (Inflammations)
02/2017 - 01/2012
4Urinary Bladder Neoplasms (Bladder Cancer)
08/2022 - 05/2014
4Necrosis
01/2021 - 02/2009
4Neuroinflammatory Diseases
03/2020 - 04/2010
3Bipolar Disorder (Manic Depressive Psychosis)
01/2021 - 12/2016
3Hyperhomocysteinemia
12/2015 - 03/2010
3Epilepsy (Aura)
12/2012 - 06/2003
3Mitochondrial Diseases (Mitochondrial Disease)
12/2012 - 02/2011
3Seizures (Absence Seizure)
12/2012 - 06/2003
3Hypothyroidism
04/2006 - 10/2004
2Mental Disorders (Mental Disorder)
01/2021 - 09/2004
2Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 03/2010
2Vascular Diseases (Vascular Disease)
09/2020 - 12/2015
2Mania (Manias)
03/2020 - 01/2016
2Pain (Aches)
01/2016 - 11/2003
2Coronary Artery Disease (Coronary Atherosclerosis)
12/2015 - 12/2013
2Peripheral Vascular Diseases (Peripheral Vascular Disease)
12/2015 - 12/2013
2Thrombosis (Thrombus)
12/2013 - 03/2010
2Status Epilepticus (Complex Partial Status Epilepticus)
12/2012 - 06/2010
2Brain Neoplasms (Brain Tumor)
06/2012 - 08/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
07/2011 - 04/2010
2Familial Polythelia
10/2009 - 02/2009
2Hyperthyroidism
10/2004 - 11/2003
1Urinary Bladder Diseases (Bladder Diseases)
08/2022
1Residual Neoplasm
01/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Schizophrenia (Dementia Praecox)
01/2021
1Overweight
01/2021
1Myocardial Infarction
09/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

16Adenosine Triphosphate (ATP)IBA
09/2020 - 01/2002
16Adenosine (Adenocard)FDA LinkGeneric
09/2020 - 06/2003
13EnzymesIBA
01/2021 - 06/2003
105'-Nucleotidase (5' Nucleotidase)IBA
03/2018 - 06/2003
7Purinergic Receptors (Receptors, Purine)IBA
08/2022 - 01/2013
7Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2008
7Adenosine Monophosphate (AMP)IBA
01/2020 - 06/2003
7NucleotidesIBA
01/2020 - 11/2003
7Adenosine Diphosphate (ADP)IBA
01/2020 - 06/2003
4LithiumIBA
01/2021 - 09/2004
3Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2014
3Dextroamphetamine (Dexedrine)FDA LinkGeneric
01/2021 - 01/2016
3Purinergic P2X7 ReceptorsIBA
03/2020 - 12/2012
3Apyrase (ATP Diphosphatase)IBA
01/2020 - 06/2003
3Adenine NucleotidesIBA
01/2019 - 02/2005
3monastrolIBA
06/2018 - 10/2013
3Pharmaceutical PreparationsIBA
05/2018 - 06/2009
3Temozolomide (Temodar)FDA LinkGeneric
01/2016 - 02/2009
3Messenger RNA (mRNA)IBA
12/2012 - 12/2008
2purineIBA
07/2021 - 03/2020
2LigandsIBA
12/2020 - 06/2018
2SolutionsIBA
11/2020 - 05/2020
2beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
11/2020 - 11/2013
2brilliant blue (brilliant blue FCF)IBA
03/2020 - 01/2016
2Biological ProductsIBA
01/2019 - 02/2009
2KinesinsIBA
06/2018 - 04/2014
2Caspase 3 (Caspase-3)IBA
09/2017 - 01/2016
2HomocysteineIBA
12/2015 - 12/2013
2CytokinesIBA
12/2015 - 05/2015
2Conditioned Culture MediaIBA
05/2015 - 07/2011
2quinovic acidIBA
01/2015 - 05/2014
2GlycosidesIBA
01/2015 - 05/2014
2Drinking WaterIBA
09/2014 - 02/2005
2CurcuminIBA
02/2013 - 06/2012
2Pilocarpine (Ocusert)FDA LinkGeneric
12/2012 - 06/2010
2Anticonvulsants (Antiepileptic Drugs)IBA
12/2012 - 06/2003
2adenylyl(3'-5')cytidine-3'-phosphateIBA
01/2012 - 12/2008
2Dihydrotachysterol (AT 10)IBA
10/2009 - 02/2009
1Biological FactorsIBA
01/2022
12,6- dichloro- 9- (1- (p- nitrobenzenesulfonyl)- 1,2,3,5- tetrahydro- 4,1- benzoxazepin- 3- yl)- 9H- purineIBA
07/2021
1Uric Acid (Urate)IBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1Methotrexate (Mexate)FDA LinkGeneric
01/2021
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2021
1TubulinIBA
12/2020
1Tubulin ModulatorsIBA
12/2020
1ColchicineFDA LinkGeneric
12/2020
1Phosphates (Orthophosphate)IBA
09/2020
1kaempferolIBA
05/2018
1ChitosanIBA
05/2018
1Ursolic AcidIBA
09/2017
1NucleotidasesIBA
02/2017
1bisabolol (levomenol)IBA
01/2017
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2016
1pyridineIBA
01/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016
1Thiobarbituric Acid Reactive SubstancesIBA
01/2016
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2016
1Antihypertensive Agents (Antihypertensives)IBA
01/2016
1Doxazosin (Cardura)FDA LinkGeneric
01/2016
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2016
1Interleukin-6 (Interleukin 6)IBA
01/2016

Therapy/Procedure

7Therapeutics
01/2022 - 06/2009
4Radiotherapy
08/2022 - 08/2007
3Drug Therapy (Chemotherapy)
01/2021 - 08/2007
2Intranasal Administration
01/2020 - 05/2018
2Ketogenic Diet
12/2012 - 06/2010